跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 221 条关于
“ALAQ”
全部
221
临床试验
182
药物
23
机构
5
资讯
11
11个月前
Phase 3 Trial Launches for Novel Triple-Drug Malaria Treatment to Combat Artemisinin Resistance
19天前
FDA Issues Untitled Letter to Alar Pharmaceuticals Over Promotion of Unapproved Ketamine Drug ALA-3000
5个月前
Alar Pharmaceuticals Reports Breakthrough Phase 1 Results for Long-Acting Ketamine Injectable ALA-3000 in Treatment-Resistant Depression
去年
BlueSphere Bio Appoints Immunotherapy Pioneer Alan Korman as Chief Scientific Officer
11个月前
Revolution Medicines Appoints Alan Sandler as Chief Development Officer to Advance RAS-Targeted Cancer Pipeline
9个月前
PharmAla Biotech Advances MDMA Manufacturing and Novel ALA-002 Development for Clinical Trials
去年
Roche's $1.5B Acquisition of Poseida Therapeutics Highlights Cell Therapy's Potential; Arovella Therapeutics (ALA) Poised for Phase 1 Trial
8个月前
Arovella Submits IND Application for First-in-Human Trial of CAR-iNKT Cell Therapy ALA-101
去年
Arovella Therapeutics Secures $20M to Advance ALA-101 Clinical Trial and iNKT Cell Therapy Pipeline
上个月
Jupiter Neurosciences Secures Exclusive U.S. Rights to PharmAla's ALA-002 in Deal Valued at Up to $100 Million
第 1 页,共 2 页
上一页
下一页